Abstract
Objective Parkinson’s Disease (PD) is a neurological disorder characterized by impaired postural control (PC) and balance issues. To date, few studies have explored the relationship between brain activity and responses during specific tasks designed to challenge balance in individuals with PD. Our exploratory research employs an innovative paradigm to assess PC by integrating virtual reality (VR) and electroencephalography (EEG).
Approach In the study, 20 individuals diagnosed with PD who self-reported postural instability participated in the BioVRSea paradigm. This paradigm tested their PC using visuomotor stimuli and collected EEG signals to assess brain responses throughout the experiment. The results of the Parkinson’s group were compared with those of 22 age-matched healthy controls (CTR). From functional connectivity between brain regions, we employed novel techniques that use clustering algorithms to identify brain network states (BNSs). These BNSs define brain dynamics and can be compared with resting-state networks (RSNs) to further explore and identify neural alterations in individuals with PD.
Main Results Six distinct BNSs were identified, with the dorsal attention network (DAN) dominant in five states. A significant reduction in the occurrence of BNS2 (p=0.005) was observed in PD patients during the PRE movement and visuomotor (MOV) phases compared to CTR. This reduced occurrence of BNS2 suggests impaired visuomotor integration in PD patients during PC tasks. DAN dominance highlights its crucial role in maintaining attentional control during the task.
Significance The findings of this study highlight the potential of using brain dynamics as a biomarker of neural dysfunction in PD, especially during specific PC tasks. Altered BNSs, particularly in networks associated with attention and sensorimotor integration, reveal key neural deficits related to PD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants received detailed written information about the study and provided their signed informed consent. The research was conducted in accordance with the principles embodied in the Declaration of Helsinki and in accordance with Icelandic statutory requirements. The study protocol was approved by the Icelandic National Bioethics Committee (no: 17–183-S1 and VSN-20–101).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
The data are not available as they pertain to individuals with medical conditions and are therefore subject to privacy and confidentiality restrictions. The scripts are available upon request, as the methodology is still in draft form.
